1800 202 8726
Kidney side effects

Kidney Function Changes — on Targeted Therapy

A rise in creatinine during targeted therapy is one of the more common findings in routine blood tests. Many rises are mild and managed with dose adjustments. Some are a warning that the kidneys need urgent help.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026

  • Mild rises are expected — Some targeted therapies routinely affect kidney blood flow or tubular function, and a small creatinine rise is monitored, not automatically alarming.
  • Your blood tests track it — Regular monitoring is built into your treatment schedule specifically to catch changes before they become serious.
  • Symptoms matter more than the number — Reduced urine, swelling, confusion, or breathlessness alongside a creatinine rise means call today, not wait for your next test.
  • Caught early, it is manageable — Dose reduction or a treatment pause, along with good hydration, resolves most mild kidney changes.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Speak to our team now

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A creatinine rise on targeted therapy means the kidneys are under more strain than usual. Mild rises are common with drugs that affect kidney blood flow or tubules, and your team monitors for them. Whether yours needs action depends on how much it has changed, how fast, and whether you have symptoms — not the number alone.

If a symptom below applies to you, do not wait for a callback. Call 1800-202-8726 or go to your nearest emergency department.

How do you tell a mild kidney change from one that needs urgent review?

FeatureLikely mild — still tell your teamNeeds same-day contact or emergency review
Urine outputNormal amount and colourNoticeably less than usual, or dark, or blood-tinged
SwellingNone, or mild ankle swelling already presentNew swelling in legs, face or hands, especially with breathlessness
Energy and alertnessTired but able to functionConfused, very drowsy, or hard to rouse
Nausea and vomitingMild, able to keep fluids downUnable to drink enough to stay hydrated
Typically startsWeeks to months into treatment; caught on a routine blood testCan occur at any point; symptoms appear on top of a rising creatinine

Why does targeted therapy affect creatinine?

Many targeted therapies — particularly those that block VEGF signalling — reduce blood flow to the kidneys as part of how they work. The kidneys respond by filtering less efficiently, and creatinine, a waste product the kidneys normally clear, begins to build up in the blood.

Other targeted drugs can affect the kidney tubules directly, or cause changes in small kidney blood vessels. The pattern of change tells your oncologist which mechanism is most likely and what to do about it.

A mild rise picked up on routine bloods is not kidney failure. It is information your team acts on — usually by reviewing hydration, checking other medications, or considering a dose adjustment.

If you are worried right now, call

Our helpline is answered by clinical staff. If a symptom is on the list above, do not wait for a callback — call, or go to your nearest emergency department.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Not sure whether this counts as an emergency?

Call the helpline. It is always better to check than to wait.

Book Free Consultation Call 1800 202 8726

What helps at home, and when does that stop being enough?

Staying well hydrated is the most useful thing you can do. Your team will likely give you a daily fluid target — follow it even on days when you do not feel thirsty, because thirst is an unreliable guide during treatment.

Avoid non-steroidal anti-inflammatory drugs such as ibuprofen, diclofenac, and naproxen. These reduce kidney blood flow and can tip a compensated kidney into a serious problem. Paracetamol at the right dose is generally safer — confirm the dose with your team given your current kidney function.

Home management stops being enough the moment you notice any symptom from the red flags above, or if you feel clearly worse despite drinking well. A sharply rising creatinine between two blood tests is something your team needs to act on that day, not at the next scheduled visit.

Questions your family is likely asking

Will my kidneys recover when treatment stops?

For most mild-to-moderate rises caused by VEGF-targeting drugs, kidney function improves when the drug is paused or stopped, because the mechanism is largely reversible. How much recovers depends on how long the change went on, how severe it became, and whether you had any pre-existing kidney condition before treatment. This is not a guarantee of full recovery in every case — your oncologist will discuss what the trajectory looks like for your specific situation and test results.

Does this mean my targeted therapy will have to stop?

Not automatically. Mild kidney changes are often managed with dose reduction, a short treatment pause, or improved hydration, and many people continue treatment successfully. A more significant rise may require a longer hold, a switch to a different drug, or a referral to a kidney specialist alongside your oncologist. The decision depends on how well the change responds to those measures and how well the cancer is responding to the current treatment — your oncologist weighs both.

Is it safe to take herbal supplements or ayurvedic medicines alongside targeted therapy?

This is an important question, and we are glad you are asking rather than assuming. Many herbal and ayurvedic preparations are cleared by the kidneys, and some have known interactions with targeted therapies — including effects on how the drugs are processed and eliminated. A kidney already under strain from treatment is more vulnerable to additional load from other substances. Please tell your treating team everything you are taking, including supplements and traditional medicines, without hesitation. They are not asking to judge the practice but to keep you safe.

My creatinine was normal last month. How much of a rise is serious?

The specific threshold your team is watching for depends on your baseline and the drug you are on — those numbers should come from your oncologist rather than a general guide. What matters more than any single reading is the direction and speed of change. A rapid rise over a short time is more concerning than a gradual one, and any rise that comes with symptoms is more concerning than one caught silently on a blood test. Ask your team at your next appointment what they are watching for and at what point they would act.

Can we protect the kidneys with other medication and keep the same targeted therapy?

Sometimes. Oncology and nephrology teams sometimes work together to use additional measures to support kidney function, particularly if the targeted therapy is working well and alternatives are limited. This is a decision for your oncologist and, if needed, a kidney specialist to make together — it is not something to start independently. Raise it as a specific question at your next appointment: ask whether kidney-protective measures exist that would allow you to continue on the current drug.

Did you know?

VEGF-signalling inhibitors — a large group of targeted therapies used in kidney, liver, thyroid and other cancers — depend on the same molecular pathway the kidneys use to maintain blood flow through their filtering units.

This is why kidney monitoring is built into targeted therapy protocols from the first cycle, not added as an afterthought when a problem appears.

Source: NCCN Guidelines for Management of Toxicities from Targeted Therapies

Explore 108 more Side Effects, Emergencies & Daily Living topics

Side Effects - Symptom-Specific Deep Dives

All Side Effects, Emergencies & Daily Living →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is a rising creatinine on targeted therapy always serious?

No. A mild rise caught on routine blood tests is a common and expected finding with many targeted therapies, particularly those that affect kidney blood flow. What makes it serious is how large the rise is, how fast it has occurred, whether it is continuing to climb, and whether you have any symptoms alongside it. A single mildly elevated result in an otherwise well person is monitored, not treated as an emergency. Your oncologist will tell you where your result sits on that spectrum.

What blood tests check kidney function during targeted therapy?

Creatinine is the most commonly monitored marker, appearing on the routine panel checked before each cycle. Your team may also look at blood urea nitrogen, electrolytes such as potassium and sodium, and urine protein — because some targeted therapies cause protein to leak into urine before creatinine rises noticeably. If a significant problem is suspected, further tests including a urine collection over 24 hours or kidney imaging may be arranged.

Can drinking more water bring my creatinine down?

Good hydration helps the kidneys work as efficiently as possible and can prevent dehydration from making an underlying change worse. It will not reverse a creatinine rise caused by the drug's direct effect on kidney blood flow or tubules. Think of hydration as maintaining the best conditions for your kidneys to cope, not as a treatment for the rise itself. Your team will give you a specific fluid target — follow that rather than drinking an unlimited amount, as very large volumes can occasionally cause problems of their own.

Should I stop ibuprofen and other painkillers?

Yes. Non-steroidal anti-inflammatory drugs — including ibuprofen, diclofenac, naproxen, and aspirin at anti-inflammatory doses — reduce blood flow to the kidneys and can significantly worsen a creatinine rise during targeted therapy. Your team should have advised you to avoid them when treatment started; if that was not discussed, raise it at your next appointment. Paracetamol at the dose your team recommends is generally a safer alternative for pain or fever, though confirm the right dose given your current kidney function.

Will CION refer me to a kidney specialist if my creatinine rises significantly?

Yes, if the rise is significant or not responding to initial measures, your oncology team may involve a nephrologist — a kidney specialist — to review your care alongside them. This is standard management for more serious kidney changes and does not mean your cancer treatment has failed or that a separate problem has been found. The two teams work together to find the approach that keeps both your treatment and your kidney function on the best possible track.

Call now Book free consultation